Market Overview:
The global sexually transmitted diseases (STD) testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of STDs, growing awareness about STDs and their prevention, and technological advancements in STD testing methods. The global STD testing market is segmented on the basis of type into chlamydia, syphilis, gonorrhea, herpes simplex virus (HSV), human papilloma virus (HPV), human immunodeficiency virus (HIV), and others. The HPV segment is expected to grow at the highest CAGR during the forecast period owing to rising awareness about HPV-related cancers and its prevention. On the basis of application, the global STD testing market is divided into laboratory testing and point-of-care (POC)testing.(Source: MarketsandMarkets Research Pvt Ltd.
 Testing Industry Outlook.svg)
Product Definition:
A sexually transmitted disease (STD) is a disease that can be passed from one person to another through sexual contact. STDs can affect men and women of all ages and backgrounds. Some STDs are more common than others.
Testing for sexually transmitted diseases is important because it can help you or your partner get treated if you have an STD, and it can help prevent the spread of STDs to other people. There are many different ways to test for STDs, including blood tests, urine tests, and swab tests.
Chlamydia:
Chlamydia is a common bacterial infection of the urinary tract and reproductive organs. It can also infect the rectum, urethra, and vagina. The disease is easily diagnosed by testing for antibodies in the patient's blood.
Syphilis:
Syphilis is a communicable disease caused by the bacterium Treponema pallidum. The disease may go unnoticed in its early stages. However, if it is not treated at the primary stage, it can result in severe damage to several body parts such as bones, heart and brain.
Application Insights:
Laboratory testing segment dominated the global market in terms of revenue in 2017. This is due to a rise in the number of individuals that undergo tests for various diseases, such as chlamydia, gonorrhea, syphilis and HIV. Moreover, an increase in government initiatives to raise awareness about STD testing is also expected to boost growth over the forecast period. For instance, U.K.-based Terrence Higgins Trust (THT) has been working towards improving access to STI services by providing funding for clinics and promoting awareness about available diagnostic tests since its inception back in 1988 till date.
Point of care testing was estimated as the fastest-growing application segment owing to an increase incidences of unintended pregnancies and high prevalence levels of chlamydia among women who are sexually active but not necessarily monogamous with their partners or have multiple sexual partners at a time.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to rising awareness about sexually transmitted diseases testing, increasing government initiatives and investments for disease control, growing healthcare expenditure by the private sector on STD testing, and presence of a large number of players in this region. For instance, according to statistics published by National Institute of Health (NIH), around 14 million people are diagnosed with chlamydia each year in the U.S., resulting in over 729 thousand reported cases annually.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure.
Growth Factors:
- Increasing incidence of STDs: The increasing incidence of STDs is a major growth driver for the STD testing market. According to the Centers for Disease Control and Prevention (CDC), there are approximately 20 million new cases of sexually transmitted infections (STIs) in the United States every year. This high incidence rate is driving demand for STD testing services, thereby fueling market growth.
- Growing awareness about STDs: There is growing awareness among people about the dangers of STDs and their symptoms. This has led to an increase in demand for STD testing services, as more people are now seeking early diagnosis and treatment for these infections.
- Rising prevalence of HIV/AIDS: The rising prevalence of HIV/AIDS is another key factor that is driving demand for STD testing services worldwide. According to estimates by the World Health Organization (WHO), around 36 million people were living with HIV/AIDS as of 2016, and this number continues to grow each year. This high prevalence rate is leading more people to get tested for HIV and other sexually transmitted diseases, thereby boosting market growth prospects..
Scope Of The Report
Report Attributes
Report Details
Report Title
Sexually Transmitted Diseases (STD) Testing Market Research Report
By Type
Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, Others
By Application
Laboratory Testing, Point of Care (POC) Testing
By Companies
ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, ORASURE, DANAHER, AFFYMETRIX, ABBOTT LABORATORIES, BIO-RAD LABORATORIES, DIASORIN
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Sexually Transmitted Diseases (STD) Testing Market Report Segments:
The global Sexually Transmitted Diseases (STD) Testing market is segmented on the basis of:
Types
Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory Testing, Point of Care (POC) Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ROCHE HOLDINGS
- BIOMERIEUX
- HOLOGIC
- BECTON DICKINSON
- ORASURE
- DANAHER
- AFFYMETRIX
- ABBOTT LABORATORIES
- BIO-RAD LABORATORIES
- DIASORIN
 Testing Market Overview.svg)
Highlights of The Sexually Transmitted Diseases (STD) Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chlamydia
- Syphilis
- Gonorrhea
- Herpes Simplex Virus
- Human Papilloma Virus
- Human Immunodeficiency Virus
- Others
- By Application:
- Laboratory Testing
- Point of Care (POC) Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sexually Transmitted Diseases (STD) Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Testing Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
STD testing is a process that helps to identify any sexually transmitted diseases (STDs) that may be present in a person. This can include tests for HIV, chlamydia, gonorrhea, and syphilis. STD testing can also help to determine whether someone is at risk for these diseases.
Some of the major companies in the sexually transmitted diseases (std) testing market are ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, ORASURE, DANAHER, AFFYMETRIX, ABBOTT LABORATORIES, BIO-RAD LABORATORIES, DIASORIN.
The sexually transmitted diseases (std) testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sexually Transmitted Diseases (STD) Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sexually Transmitted Diseases (STD) Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sexually Transmitted Diseases (STD) Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sexually Transmitted Diseases (STD) Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sexually Transmitted Diseases (STD) Testing Market Size & Forecast, 2018-2028
4.5.1 Sexually Transmitted Diseases (STD) Testing Market Size and Y-o-Y Growth
4.5.2 Sexually Transmitted Diseases (STD) Testing Market Absolute $ Opportunity
Chapter 5 Global Sexually Transmitted Diseases (STD) Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Type
5.2.1 Chlamydia
5.2.2 Syphilis
5.2.3 Gonorrhea
5.2.4 Herpes Simplex Virus
5.2.5 Human Papilloma Virus
5.2.6 Human Immunodeficiency Virus
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sexually Transmitted Diseases (STD) Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Applications
6.2.1 Laboratory Testing
6.2.2 Point of Care (POC) Testing
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sexually Transmitted Diseases (STD) Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sexually Transmitted Diseases (STD) Testing Analysis and Forecast
9.1 Introduction
9.2 North America Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Type
9.6.1 Chlamydia
9.6.2 Syphilis
9.6.3 Gonorrhea
9.6.4 Herpes Simplex Virus
9.6.5 Human Papilloma Virus
9.6.6 Human Immunodeficiency Virus
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Applications
9.10.1 Laboratory Testing
9.10.2 Point of Care (POC) Testing
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sexually Transmitted Diseases (STD) Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Type
10.6.1 Chlamydia
10.6.2 Syphilis
10.6.3 Gonorrhea
10.6.4 Herpes Simplex Virus
10.6.5 Human Papilloma Virus
10.6.6 Human Immunodeficiency Virus
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Applications
10.10.1 Laboratory Testing
10.10.2 Point of Care (POC) Testing
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sexually Transmitted Diseases (STD) Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Type
11.6.1 Chlamydia
11.6.2 Syphilis
11.6.3 Gonorrhea
11.6.4 Herpes Simplex Virus
11.6.5 Human Papilloma Virus
11.6.6 Human Immunodeficiency Virus
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Applications
11.10.1 Laboratory Testing
11.10.2 Point of Care (POC) Testing
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sexually Transmitted Diseases (STD) Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Type
12.6.1 Chlamydia
12.6.2 Syphilis
12.6.3 Gonorrhea
12.6.4 Herpes Simplex Virus
12.6.5 Human Papilloma Virus
12.6.6 Human Immunodeficiency Virus
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Applications
12.10.1 Laboratory Testing
12.10.2 Point of Care (POC) Testing
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sexually Transmitted Diseases (STD) Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Type
13.6.1 Chlamydia
13.6.2 Syphilis
13.6.3 Gonorrhea
13.6.4 Herpes Simplex Virus
13.6.5 Human Papilloma Virus
13.6.6 Human Immunodeficiency Virus
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sexually Transmitted Diseases (STD) Testing Market Size Forecast by Applications
13.10.1 Laboratory Testing
13.10.2 Point of Care (POC) Testing
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sexually Transmitted Diseases (STD) Testing Market: Competitive Dashboard
14.2 Global Sexually Transmitted Diseases (STD) Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ROCHE HOLDINGS
14.3.2 BIOMERIEUX
14.3.3 HOLOGIC
14.3.4 BECTON DICKINSON
14.3.5 ORASURE
14.3.6 DANAHER
14.3.7 AFFYMETRIX
14.3.8 ABBOTT LABORATORIES
14.3.9 BIO-RAD LABORATORIES
14.3.10 DIASORIN
